Download Citation
Article Source:
RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals
Lesch M,
Luckner M,
Meyer M,
Weege F,
Gravenstein I,
et al.
(2019)
RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.
PLOS Pathogens 15(3): e1007601.
https://doi.org/10.1371/journal.ppat.1007601